- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/06 - 1,2,3-TriazolesHydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
Patent holdings for IPC class C07D 249/06
Total number of patents in this class: 663
10-year publication summary
|
47
|
57
|
43
|
59
|
45
|
46
|
52
|
37
|
36
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
25 |
| Centre National de La Recherche Scientifique | 10418 |
16 |
| Janssen Pharmaceutica N.V. | 3392 |
12 |
| F. Hoffmann-La Roche AG | 7925 |
11 |
| Institut Curie | 584 |
10 |
| Universite de Montpellier | 985 |
10 |
| The Regents of the University of California | 19918 |
9 |
| Bayer Cropscience AG | 2035 |
9 |
| Siemens Medical Solutions USA, Inc. | 1515 |
8 |
| Roche Diagnostics Operations, Inc. | 1487 |
7 |
| Imago Biosciences, Inc. | 38 |
7 |
| The University of Queensland | 660 |
7 |
| E. I. du Pont de Nemours and Company | 4082 |
6 |
| Takeda Pharmaceutical Company Limited | 2713 |
6 |
| Arcus Biosciences, Inc. | 138 |
6 |
| FMC Corporation | 844 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 163 |
6 |
| The Research Foundation for The State University of New York | 1617 |
6 |
| Yale University | 2378 |
6 |
| Sigilon Therapeutics, Inc. | 103 |
6 |
| Other owners | 484 |